Summary of findings 2: PLD alone vs other conventional chemotherapy
Quality of life · recurrent platinum‐resistant EOC
The review found no eligible studies for this question.
1 finding from 1 review
- Pegylated liposomal doxorubicin for relapsed epithelial ovarian cancer 2023 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedNo studies found